Status:
RECRUITING
Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease
Lead Sponsor:
Berner Reha Zentrum AG
Collaborating Sponsors:
Insel Gruppe AG, University Hospital Bern
Zurich University of Applied Sciences
Conditions:
Interstitial Lung Disease
Fibrotic Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
Patients with fibrotic insterstitial lung disease (ILD) participating in inpatient rehabilitation or in outpatient pulmonary care will be invited to participate in this observational study. Patients w...
Eligibility Criteria
Inclusion
- Inclusion criteria are:
- For Berner Reha Zentrum only: Diagnosis of a FILD as major indication for pulmonary rehabilitation
- For Inselspital only: Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose
- Age ≥ 18 years
- Written informed consent
- Exclusion criteria are:
- Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures
- Sarcoidosis
Exclusion
Key Trial Info
Start Date :
November 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06027333
Start Date
November 8 2023
End Date
August 30 2024
Last Update
March 13 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Berner Reha Zentrum, Rehabilitation & Sports Medicine, Insel Group, University Hospital Berne
Bern, Heiligenschwendi, Switzerland, 3365
2
Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern
Bern, Switzerland, 3010